Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Aust N Z J Public Health ; 34(2): 130-5, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23331355

RESUMO

OBJECTIVES: To determine acceptance, completion rates and immunogenicity of the standard vaccination schedule for hepatitis A (HAV) and B (HBV) in persons subject to homelessness. METHODS: A convenience sample of clients (n=201) attending a medical clinic for homeless and disadvantaged persons in Sydney was enrolled. Serological screening for HAV and HBV was undertaken. An appropriate vaccination program was instituted. Post-vaccination serology determined serological response. RESULTS: Although many clients had serological evidence of past infection, at least 138 (69%) clients had the potential to benefit from vaccination. For hepatitis A and B vaccinations, completion rates were 73% (73 of 100 clients) and 75% (69 of 92 clients), respectively; after vaccination, protective antibody was found in 98.2% (56 of 57) and 72% (36 of 50) of clients, respectively. CONCLUSION: A successful vaccination program can be mounted with a vulnerable population. We consider a clinic with a well-established history of acceptance and utilisation by the target group; a low staff turnover and regular clientele; inclusion of vaccination as part of routine client care; and counselling (part of pre- and post-serological testing) essential components in achieving good vaccination completion rates.


Assuntos
Vacinas contra Hepatite A/imunologia , Hepatite A/prevenção & controle , Vacinas contra Hepatite B/imunologia , Hepatite B/prevenção & controle , Pessoas Mal Alojadas , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Adolescente , Adulto , Idoso , Austrália , Feminino , Pesquisas sobre Atenção à Saúde , Hepatite A/epidemiologia , Hepatite A/imunologia , Anticorpos Anti-Hepatite A/análise , Vacinas contra Hepatite A/administração & dosagem , Hepatite B/epidemiologia , Hepatite B/imunologia , Anticorpos Anti-Hepatite B/análise , Vacinas contra Hepatite B/administração & dosagem , Humanos , Programas de Imunização/organização & administração , Masculino , Pessoa de Meia-Idade , Áreas de Pobreza , Vacinação/estatística & dados numéricos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA